.

Bristol-Myers Squibb traded at $71.09 this Friday September 30th, decreasing $0.62 or 0.86 percent since the previous trading session. Looking back, over the last four weeks, Bristol-Myers Squibb lost 5.46 percent. Over the last 12 months, its price rose by 19.46 percent. Looking ahead, we forecast Bristol-Myers Squibb to be priced at 68.96 by the end of this quarter and at 62.94 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
71.09
Daily Change
-0.86%
Yearly
19.46%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 134.21 -8.51 -5.96% 23.03%
Abbott 96.76 -1.53 -1.56% -17.45%
ALKERMES 22.33 -0.13 -0.58% -27.69%
Amgen 225.40 -3.01 -1.32% 5.37%
AstraZeneca 9,944.00 11.00 0.11% 13.35%
Astrazeneca 54.84 -0.07 -0.13% -8.11%
Biogen 267.00 2.72 1.03% -5.97%
Bristol-Myers Squibb 71.09 -0.62 -0.86% 19.46%
Coherus Biosciences 9.61 0.26 2.78% -41.83%
Catalent 72.36 -1.92 -2.58% -45.15%
Endo International 0.10 -0.01 -5.47% -97.18%
Gilead Sciences 61.69 -1.38 -2.19% -10.02%
GlaxoSmithKline 1,305.80 -10.00 -0.76% -5.76%
Horizon Pharma 61.89 -0.80 -1.28% -43.67%
Intercept Pharmaceuticals 13.95 -2.46 -14.99% -8.34%
Jazz Pharmaceuticals 133.29 0.87 0.66% 2.55%
J&J 163.36 -1.17 -0.71% 1.80%
Lannett 0.45 -0.01 -2.79% -84.64%
Eli Lilly 323.35 -6.66 -2.02% 40.84%
Medtronic 80.75 -1.52 -1.85% -36.57%
Merck & Co 86.12 -0.52 -0.60% 5.80%
Novartis 75.53 0.61 0.81% -0.70%
Phibro Animal Health 13.29 0.12 0.91% -38.47%
Prestige Brands 49.83 -0.34 -0.68% -10.07%
Pfizer 43.76 -0.40 -0.91% 1.93%
Perrigo 35.66 -0.29 -0.81% -26.57%
Drreddys Laboratories 52.34 0.12 0.23% -21.09%
Regeneron Pharmaceuticals 688.87 -2.95 -0.43% 20.69%
Roche Holding 323.45 3.20 1.00% -6.31%
Revance Therapeutics 27.00 1.33 5.18% -3.12%
Sanofi 78.40 0.56 0.72% -5.10%
Sanofi 38.02 0.02 0.05% -20.63%
Teva Pharmaceutical Industries 8.07 0.25 3.20% -16.80%
United Therapeutics 209.38 1.44 0.69% 12.63%
Zoetis 148.29 -2.66 -1.76% -24.42%

Indexes Price Day Year
US500 3563 -54.85 -1.51% -18.47%

Bristol-Myers Squibb
Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Its pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. Its products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics and government agencies.